Evotec SE has a consensus price target of $13.33 based on the ratings of 6 analysts. The high is $16 issued by Morgan Stanley on June 23, 2023. The low is $11 issued by HC Wainwright & Co. on May 23, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 23, 2024, April 25, 2024, and August 31, 2023, respectively. With an average price target of $12 between HC Wainwright & Co., there's an implied 155.23% upside for Evotec SE from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/23/2024 | Buy Now | 133.96% | HC Wainwright & Co. | Douglas Tsao | → $11 | Reiterates | Buy → Buy | Get Alert |
04/25/2024 | Buy Now | 133.96% | HC Wainwright & Co. | Douglas Tsao | $14 → $11 | Maintains | Buy | Get Alert |
08/31/2023 | Buy Now | 197.76% | HC Wainwright & Co. | Douglas Tsao | $12 → $14 | Maintains | Buy | Get Alert |
07/12/2023 | Buy Now | 155.23% | HC Wainwright & Co. | Douglas Tsao | → $12 | Reiterates | Buy → Buy | Get Alert |
06/23/2023 | Buy Now | 240.3% | Morgan Stanley | James Quigley | $12 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
06/16/2023 | Buy Now | 176.5% | B of A Securities | Derik De Bruin | → $13 | Downgrade | Buy → Neutral | Get Alert |
06/08/2023 | Buy Now | — | Citigroup | Peter Verdult | — | Upgrade | Neutral → Buy | Get Alert |
04/04/2023 | Buy Now | — | Morgan Stanley | James Quigley | — | Upgrade | Underweight → Equal-Weight | Get Alert |
03/29/2023 | Buy Now | 155.23% | HC Wainwright & Co. | Douglas Tsao | → $12 | Reiterates | → Buy | Get Alert |
01/27/2023 | Buy Now | 155.23% | HC Wainwright & Co. | Douglas Tsao | → $12 | Reiterates | → Buy | Get Alert |
12/09/2022 | Buy Now | 155.23% | HC Wainwright & Co. | Douglas Tsao | → $12 | Initiates | → Buy | Get Alert |
11/16/2022 | Buy Now | — | Deutsche Bank | Falko Friedrichs | — | Downgrade | Buy → Hold | Get Alert |
08/10/2022 | Buy Now | 240.3% | Morgan Stanley | James Quigley | → $16 | Downgrade | Overweight → Underweight | Get Alert |
11/29/2021 | Buy Now | — | Cowen & Co. | Max Masucci | — | Initiates | → Outperform | Get Alert |
The latest price target for Evotec (NASDAQ:EVO) was reported by HC Wainwright & Co. on May 23, 2024. The analyst firm set a price target for $11.00 expecting EVO to rise to within 12 months (a possible 133.96% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Evotec (NASDAQ:EVO) was provided by HC Wainwright & Co., and Evotec reiterated their buy rating.
The last upgrade for Evotec SE happened on June 23, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Evotec SE.
The last downgrade for Evotec SE happened on June 16, 2023 when B of A Securities changed their price target from N/A to $13 for Evotec SE.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Evotec, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Evotec was filed on May 23, 2024 so you should expect the next rating to be made available sometime around May 23, 2025.
While ratings are subjective and will change, the latest Evotec (EVO) rating was a reiterated with a price target of $11.00 to $11.00. The current price Evotec (EVO) is trading at is $4.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.